Document Detail

Parvovirus B19 infection in children with a variety of hematological disorders.
MedLine Citation:
PMID:  17178665     Owner:  NLM     Status:  MEDLINE    
This study was carried out to detect Parvovirus B19 (PB19) DNA together with its antibodies in the sera of children with a range of hematological disorders to clarify the contribution of this infection to changes observed in hematological picture in those populations. This study included 85 pediatric patients with different hematological disorders. Twenty healthy subjects with matched age and sex were included as controls. Patients were classified into four groups; group I included 25 patients with hemolytic anemia in aplastic crisis, group II included 20 patients with hemolytic anemia without aplastic crisis, group III included 20 acute leukemia patients under chemotherapy, group IV included 20 patients with recently diagnosed acute leukemia. Virological study for PB19 included determination of specific IgG & IgM together with viral DNA by polymerase chain reaction (PCR). In all groups of patients with positive markers for PB19, there were statistically significant differences in the mean Hb concentration and RBC count (P < 0.001 for each), presence of neutropenia (P = 0.003) and lymphocytosis (P < 0.001) compared to controls. There was statistically significant difference in the prevalence of PB19 IgM, IgG and PCR among studied groups compared to control group. In group I and group II IgG had the highest positive rate (56 and 35%, respectively). In group III IgG also had a high positive rate (45%). However, in group IV IgM had the highest positive rate (50%) followed by PCR (45%) then IgG (40%). In conclusion, PB19 infection is detected in high rates among children with hematological disorders. PB19 must be suspected and screened for when there is anemia in those patients associated with neutropenia and lymphocytosis. In patients with acute leukaemia under chemotherapy who have unexpected anemia, neutropenia and lymphocytosis Parvovirus infection should be considered before a change of chemotherapy protocol. Screening of blood for PB19 may be helpful in understanding the epidemiology of infection with this virus. The direct detection of DNA by PCR in sera needs to be coupled with serology for a more reliable diagnosis of PB19 infections in these children.
Maysaa El Sayed Zaki; Samir AbouEl Hassan; Tarek Seleim; Rania AbdEl Lateef
Related Documents :
3517275 - Antibiotic therapy in cystic fibrosis: evaluation of clinical trials.
14699455 - Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and ...
10357295 - Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis.
17532715 - Efficacy and tolerability of sequential intravenous/oral moxifloxacin therapy in pneumo...
11180305 - Putting theory into practice: a cluster randomized trial with a small number of clusters.
15106195 - Methotrexate for multiple sclerosis.
Publication Detail:
Type:  Comparative Study; Historical Article; Journal Article    
Journal Detail:
Title:  Hematology (Amsterdam, Netherlands)     Volume:  11     ISSN:  1607-8454     ISO Abbreviation:  Hematology     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-12-20     Completed Date:  2007-03-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9708388     Medline TA:  Hematology     Country:  England    
Other Details:
Languages:  eng     Pagination:  261-6     Citation Subset:  IM    
Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia, Aplastic / epidemiology,  virology
Anemia, Hemolytic / epidemiology,  virology
Antibodies, Viral / blood
DNA, Viral / blood
Egypt / epidemiology
Hematologic Diseases / epidemiology*,  virology
History, Medieval
Immunoglobulin G / blood
Immunoglobulin M / blood
Leukemia / epidemiology,  virology
Lymphocytosis / epidemiology,  virology
Neutropenia / epidemiology,  virology
Parvoviridae Infections / blood,  epidemiology*,  virology
Parvovirus B19, Human / genetics,  immunology,  isolation & purification*,  pathogenicity
Polymerase Chain Reaction
Reg. No./Substance:
0/Antibodies, Viral; 0/DNA, Viral; 0/Immunoglobulin G; 0/Immunoglobulin M

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Parvovirus B-19 induced acute pure red cell aplasia in patients with chronic lymphocytic leukemia an...
Next Document:  Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.